Insights into Structure-Activity Relationships of Somatostatin Analogs Containing Mesitylalanine.

dc.contributor.authorMartín-Gago, Pablo
dc.contributor.authorAragón Altarriba, Eric
dc.contributor.authorGomez-Caminals, Marc
dc.contributor.authorFernández-Carneado, Jimena
dc.contributor.authorRamón, Rosario
dc.contributor.authorMartin-Malpartida, Pau
dc.contributor.authorVerdaguer i Espaulella, Xavier
dc.contributor.authorLópez-Ruiz, Pilar
dc.contributor.authorColás, Begoña
dc.contributor.authorCortes, María Alicia
dc.contributor.authorPonsati, Berta
dc.contributor.authorMacías Hernández, María J.
dc.contributor.authorRiera i Escalé, Antoni
dc.date.accessioned2014-01-29T12:37:52Z
dc.date.available2014-01-29T12:37:52Z
dc.date.issued2013-11-25
dc.date.updated2014-01-29T12:37:52Z
dc.description.abstractThe non-natural amino acid mesitylalanine (2,4,6-trimethyl-L-phenylalanine; Msa) has an electron-richer and a more conformationally restricted side-chain than that of its natural phenylalanine counterpart. Taking these properties into account, we have synthesized ten somatostatin analogs containing Msa residues in different key positions to modify the intrinsic conformational flexibility of the natural hormone. We have measured the binding affinity of these analogs and correlated it with the main conformations they populate in solution. NMR and computational analysis revealed that analogs containing one Msa residue were conformationally more restricted than somatostatin under similar experimental conditions. Furthermore, we were able to characterize the presence of a hairpin at the pharmacophore region and a non-covalent interaction between aromatic residues 6 and 11. In all cases, the inclusion of a D-Trp in the eighth position further stabilized the main conformation. Some of these peptides bound selectively to one or two somatostatin receptors with similar or even higher affinity than the natural hormone. However, we also found that multiple incorporations of Msa residues increased the life span of the peptides in serum but with a loss of conformational rigidity and binding affinity.
dc.format.extent21 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec632486
dc.identifier.issn1420-3049
dc.identifier.pmid24287991
dc.identifier.urihttps://hdl.handle.net/2445/49258
dc.language.isoeng
dc.publisherMDPI Publishing
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.3390/molecules181214564
dc.relation.ispartofMolecules, 2013, vol. 18, num. 12, p. 14564-14584
dc.relation.urihttp://dx.doi.org/10.3390/molecules181214564
dc.rightscc-by (c) Martín-Gago, Pablo et al., 2013
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Química Inorgànica i Orgànica)
dc.subject.classificationSomatostatina
dc.subject.classificationHormones peptídiques
dc.subject.classificationDisseny de medicaments
dc.subject.classificationRessonància magnètica nuclear
dc.subject.classificationAnàlisi conformacional
dc.subject.otherSomatostatin
dc.subject.otherPeptide hormones
dc.subject.otherDrug design
dc.subject.otherNuclear magnetic resonance
dc.subject.otherConformational analysis
dc.titleInsights into Structure-Activity Relationships of Somatostatin Analogs Containing Mesitylalanine.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
632486.pdf
Mida:
2.27 MB
Format:
Adobe Portable Document Format